Compare HFFG & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HFFG | INO |
|---|---|---|
| Founded | 1997 | 1979 |
| Country | United States | United States |
| Employees | 960 | N/A |
| Industry | Food Distributors | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.8M | 114.0M |
| IPO Year | 2016 | 1999 |
| Metric | HFFG | INO |
|---|---|---|
| Price | $1.86 | $1.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.00 | ★ $6.75 |
| AVG Volume (30 Days) | 129.2K | ★ 3.7M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.65 | ★ 54.18 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,228,282,000.00 | $42,220,086.00 |
| Revenue This Year | $5.59 | $20,156.19 |
| Revenue Next Year | $2.24 | $421.95 |
| P/E Ratio | $92.00 | ★ N/A |
| Revenue Growth | 2.21 | ★ 19.37 |
| 52 Week Low | $1.38 | $1.03 |
| 52 Week High | $3.86 | $2.86 |
| Indicator | HFFG | INO |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 43.24 |
| Support Level | $1.73 | $1.03 |
| Resistance Level | $2.30 | $1.23 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 14.75 | 15.62 |
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, frozen and dry food, and non-food products to Asian restaurants and other foodservice customers throughout the United States. The company's business consists of one operating segment: HF Group, which operates solely in the United States. The company's product list consists of Meat, Poultry & Seafood, Sauces & Oils, Takeout Items (Boxes, Chopsticks & Utensils), Raw Ingredients (Flour, Cornstarch, Spices), Cleaning Supplies, and Rice & Grains.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.